Edition:
United States

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

36.99USD
15 Dec 2017
Change (% chg)

$-0.37 (-0.99%)
Prev Close
$37.36
Open
$37.36
Day's High
$37.36
Day's Low
$36.49
Volume
17,893
Avg. Vol
47,271
52-wk High
$42.00
52-wk Low
$19.34

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.43 -1.039
Jun '17 0.44 -0.945
Mar '17 0.37 -0.775
FY 2016 Dec '16 1.04 -0.535
Sep '16 1.17 -0.724
Jun '16 1.14 -0.528
Mar '16 1.26 -0.817
FY 2015 Dec '15 1.98 -0.477
Sep '15 2.12 -0.298
Jun '15 1.94 -0.627
Mar '15 2.08 0.058
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 6 0.33 0.51 0.00 0.57
Quarter Ending Mar-18 2 0.75 1.10 0.40 --
Year Ending Dec-17 6 1.73 2.00 1.50 2.23
Year Ending Dec-18 6 2.04 4.25 0.80 2.34
Earnings (per share)
Quarter Ending Dec-17 5 -0.79 -0.60 -0.94 -0.44
Quarter Ending Mar-18 3 -0.74 -0.62 -0.89 --
Year Ending Dec-17 6 -3.47 -2.87 -3.66 -1.98
Year Ending Dec-18 6 -3.12 -2.48 -3.53 -2.41
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 198.20 35.91
P/E High - Last 5 Yrs. -- 280.37 45.35
P/E Low - Last 5 Yrs. -- 93.75 24.23
Beta -- 0.82 0.91
Price to Sales (TTM) 497.03 122.78 5.95
Price to Book (MRQ) 5.64 23.45 5.68
Price to Tangible Book (MRQ) 5.74 27.39 7.29
Price to Cash Flow (TTM) -- 108.78 24.49
% Owned Institutions 79.88 5.61 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -62.87 -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago -58.61 29.98 5.62
Sales - 5 Yr. Growth Rate -- 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago -43.40 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago -29.37 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate -- 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) 10.85 5.62 3.56
LT Debt to Equity (MRQ) 0.00 16.22 13.38
Total Debt to Equity (MRQ) 0.00 18.71 19.38
Interest Coverage (TTM) -- -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) -4,414.52 -- --
EBITD - 5 Yr. Avg -- -215.66 15.63
Operating Margin (TTM) -4,445.49 -642.63 6.56
Operating Margin - 5 Yr. Avg. -- -232.87 11.00
Pre-Tax Margin (TTM) -4,641.91 -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -- -233.04 11.41
Net Profit Margin (TTM) -4,630.18 -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -- -236.43 7.70
Effective Tax Rate (TTM) -- 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 26,680 22,314,532 851,801,741
Net Income/Employee (TTM) -1,235,355 -1,997,855 99,542,701
Receivable Turnover (TTM) 5.31 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) 0.01 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -68.76 -9.39 11.31
Return on Assets - 5 Yr. Avg. -- 0.28 12.28
Return on Investment (TTM) -76.78 -11.76 14.43
Return on Investment - 5 Yr. Avg. -- 3.42 16.07
Return on Equity (TTM) -76.78 -36.72 16.01
Return on Equity - 5 Yr. Avg. -- 5.75 17.27
  1 Year 3 Year 5 Year
Sales % -43.26 -39.12 --
EPS (TTM) % -86.17 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ascendis Pharma A/S

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -0.30 -3.91 49 94
13 Week 24.64 16.46 81 75
26 Week 53.46 39.54 85 59
52 Week 76.22 48.97 82 58
YTD 81.97 52.25 84 51
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 79.90%
# of Holders: 73
Total Shares Held: 29,056,920
3 Mo. Net Change: 5,537,745
# New Positions: 31
# Closed Positions: 2
# Increased Positions: 56
# Reduced Positions: 13
# Net Buyers: 43
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.